Carisma Therapeutics names new Chief Medical Officer By Investing.com

PHILADELPHIA – Carisma Therapeutics Inc. (NASDAQ: CARM), a biopharmaceutical company specializing in immunotherapies, has appointed Eugene P. Kennedy, M.D., F.A.C.S., as its new Chief Medical Officer. Dr. Kennedy, an industry veteran with over 15 years of experience in clinical development, particularly in oncology and immuno-oncology, will oversee the company’s clinical, regulatory, and…